COMMUNIQUÉS West-GlobeNewswire

Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
12/10/2017
Press release - No. 9/2017 Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide 30 subjects have already been dosed with [...]
Shire plc : Notice of Results
12/10/2017
Shire to announce third quarter 2017 results Dublin, Ireland - October 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2017 earnings on Friday October 27, 2017. Results press release will be [...]
New data showing paradoxical rise of inpatient CAD diagnostic testing presented at German Heart Days supports the implementation of Acarix CADScor®System
12/10/2017
Press release Malmö, October 12, 2017 New data showing paradoxical rise of inpatient CAD diagnostic testing presented at German Heart Days supports the implementation of Acarix CADScor®System Non-invasive acoustic [...]
Terveystalo Oyj - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:05 am Terveystalo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rihko, Matti [...]
Terveystalo Plc - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:00 am Terveystalo Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Helsingin [...]
Terveystalo Oyj - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:00 am Terveystalo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Laurila, [...]
Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017
12/10/2017
ORION CORPORATION PRESS RELEASE 12 OCTOBER 2017 at 10.30 A.M. EEST Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017 Orion will publish its Interim Report for January- [...]
Communiqué : Nouvelle avancée dans le rapprochement entre Essilor et Luxottica - Filialisation des activités d'Essilor
12/10/2017
Nouvelle avancée dans le rapprochement entre Essilor et Luxottica Filialisation des activités d'Essilor Version PDF du communiqué Charenton-le-Pont, France (le 12 octobre 2017 - 8h30) - Le 3 octobre 2017, le Conseil d' [...]
News Release: New achievement towards the combination of Essilor and Luxottica - Hive-down of Essilor's activities
12/10/2017
New achievement towards the combination of Essilor and Luxottica Hive-down of Essilor's activities PDF Version of the news release Charenton-le-Pont, France (October 12, 2017 - 8:30 a.m.) - On October 3, 2017, the Board [...]
Change in Nexstim Plc's Management Team
12/10/2017
Company announcement, Helsinki, 12 October 2017 at 9 AM. Change in Nexstim Plc's Management Team Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing [...]
DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut
12/10/2017
Press Release Montrouge, France, October 12, 2017 DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut 97.5% of patients continue treatment in the open-label arm of the REALISE [...]
DBV Technologies annonce la fin de la première partie de l'étude REALISE de Viaskin Peanut
12/10/2017
Communiqué de presse Montrouge, France, le 12 octobre 2017 (7H30 CEST) DBV Technologies annonce la fin de la première partie de l'étude REALISE de Viaskin Peanut 97,5 % des patients poursuivent l'étude en ouvert et [...]
Sanofi invests €170 million in new vaccine production facility in France
12/10/2017
Sanofi invests €170 million in new vaccine production facility in France - Expansion at Val de Reuil reinforces the company's position as a global leader in seasonal flu vaccines - Paris, France - October 12, 2017 - [...]
Sanofi investit 170 millions d'euros dans une nouvelle unité de production en France
12/10/2017
Sanofi investit 170 millions d'euros dans une nouvelle unité de production en France - Cet agrandissement sur le site de Val de Reuil renforce la position de leader mondial de l'entreprise en vaccins contre la grippe [...]
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
12/10/2017
Oslo, Norway, 11 October 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces one-year data on [...]
Fagron: Turnover growth supported by key regions Europe, South America and North America
12/10/2017
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands) 1 , 12 October 2017 Key points Turnover increases to € 103.6 million Organic turnover growth at constant exchange rates of 2.4% Active buy-and-build [...]
Sanofi: Availability of the Pre-quarterly Results Communication
11/10/2017
Availability of the Pre-quarterly Results Communication Paris, France - October 11, 2017 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
11/10/2017
Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 11 octobre 2017 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « [...]
Merus participera au BIO Investor Forum
11/10/2017
UTRECHT, Pays-Bas, le 11 octobre 2017 (GLOBE NEWSWIRE) - Merus N.V. (NASDAQ:MRUS), une entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques, a annoncé [...]

Pages